Cargando…
Reply: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966621/ http://dx.doi.org/10.1038/sj.bjc.6605826 |
| _version_ | 1782189605612683264 |
|---|---|
| author | Hamaoka, T Costelloe, C M Madewell, J E Liu, P Hortobagyi, G N Ueno, N T |
| author_facet | Hamaoka, T Costelloe, C M Madewell, J E Liu, P Hortobagyi, G N Ueno, N T |
| author_sort | Hamaoka, T |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2966621 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-29666212011-09-07 Reply: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria Hamaoka, T Costelloe, C M Madewell, J E Liu, P Hortobagyi, G N Ueno, N T Br J Cancer Letter to the Editor Nature Publishing Group 2010-09-07 2010-07-27 /pmc/articles/PMC2966621/ http://dx.doi.org/10.1038/sj.bjc.6605826 Text en Copyright © 2010 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter to the Editor Hamaoka, T Costelloe, C M Madewell, J E Liu, P Hortobagyi, G N Ueno, N T Reply: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria |
| title | Reply: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria |
| title_full | Reply: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria |
| title_fullStr | Reply: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria |
| title_full_unstemmed | Reply: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria |
| title_short | Reply: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria |
| title_sort | reply: assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the mda response classification criteria |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966621/ http://dx.doi.org/10.1038/sj.bjc.6605826 |
| work_keys_str_mv | AT hamaokat replyassessmentoftherapeuticresponseinpatientswithmetastaticskeletaldiseasesuggestedmodificationsforthemdaresponseclassificationcriteria AT costelloecm replyassessmentoftherapeuticresponseinpatientswithmetastaticskeletaldiseasesuggestedmodificationsforthemdaresponseclassificationcriteria AT madewellje replyassessmentoftherapeuticresponseinpatientswithmetastaticskeletaldiseasesuggestedmodificationsforthemdaresponseclassificationcriteria AT liup replyassessmentoftherapeuticresponseinpatientswithmetastaticskeletaldiseasesuggestedmodificationsforthemdaresponseclassificationcriteria AT hortobagyign replyassessmentoftherapeuticresponseinpatientswithmetastaticskeletaldiseasesuggestedmodificationsforthemdaresponseclassificationcriteria AT uenont replyassessmentoftherapeuticresponseinpatientswithmetastaticskeletaldiseasesuggestedmodificationsforthemdaresponseclassificationcriteria |